Holen Sie sich die Stockscreener-App
0.4134
5.98%
0.0205
Handel nachbörslich:
.41
-0.0034
-0.82%
Schlusskurs vom Vortag:
$0.3929
Offen:
$0.412
24-Stunden-Volumen:
1.15M
Relative Volume:
1.16
Marktkapitalisierung:
$38.02M
Einnahmen:
$1.22M
Nettoeinkommen (Verlust:
$-14.15M
KGV:
-1.59
EPS:
-0.26
Netto-Cashflow:
$-6.55M
1W Leistung:
+0.85%
1M Leistung:
+2.59%
6M Leistung:
+47.97%
1J Leistung:
+13.89%
1-Tages-Spanne:
$0.3876
$0.419
1-Wochen-Bereich:
$0.38
$0.435
52-Wochen-Spanne:
$0.2525
$0.4985
IGC Pharma Inc Stock (IGC) Company Profile
Firmenname
IGC Pharma Inc
Sektor
Branche
Telefon
301-983-0998
Adresse
4336 Montgomery Avenue, Bethesda, MD
Vergleichen Sie IGC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.4134 | 36.13M | 1.22M | -14.15M | -6.55M | -0.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
IGC Pharma Inc Aktie (IGC) Neueste Nachrichten
IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of - GuruFocus
Will earnings trigger a reversal in IGC Pharma Inc.Gold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
Short interest data insights for IGC Pharma Inc.Quarterly Portfolio Review & Reliable Volume Spike Trade Alerts - newser.com
How to read the order book for IGC Pharma Inc.July 2025 Summary & Real-Time Volume Triggers - newser.com
IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida's Department of Psych - PharmiWeb.com
IGC Pharma Expands Alzheimer's Drug Trial with New Research Site - GuruFocus
4 participants enrolled: IGC Pharma expands Phase 2 CALMA trial to University of South Florida - Stock Titan
Is IGC Pharma Inc. stock poised for growthEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Will IGC Pharma Inc. stock gain from government policiesWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - newser.com
What’s next for IGC Pharma Inc. stock priceShort Setup & AI Powered Market Trend Analysis - newser.com
Is IGC Pharma Inc. a candidate for recovery playPortfolio Performance Summary & Step-by-Step Swing Trade Plans - newser.com
Full technical analysis of IGC Pharma Inc. stockWeekly Trend Report & Low Drawdown Investment Strategies - newser.com
What the charts say about IGC Pharma Inc. todayWeekly Investment Summary & Expert Approved Trade Ideas - newser.com
What downside risks could hit IGC Pharma Inc. stockJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Applying Wyckoff theory to IGC Pharma Inc. stockMarket Trend Report & Reliable Price Breakout Alerts - newser.com
Candlestick signals on IGC Pharma Inc. stock todayJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders - Lelezard
600M authorized shares: IGC Pharma boosts authorization, grants 5,000,000 shares and elects two directors - Stock Titan
What to expect from IGC Pharma Inc. in the next 30 daysTrade Exit Summary & High Accuracy Trade Alerts - newser.com
Developing predictive dashboards with IGC Pharma Inc. dataJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - newser.com
Will IGC Pharma Inc. stock profit from AI boom2025 Market Trends & Technical Buy Zone Confirmation - newser.com
IGC Pharma Subsidiary Signs Asset Sale Agreement - MSN
What candlestick patterns are forming on IGC Pharma Inc.Portfolio Update Report & Risk Adjusted Swing Trade Ideas - newser.com
How IGC Pharma Inc. stock reacts to monetary easingJuly 2025 Recap & AI Based Trade Execution Alerts - newser.com
IGC's Latest Discovery in Alzheimer's Treatment Shows Promise - GuruFocus
IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease - ACCESS Newswire
Kd 3.95 μM: IGC Pharma's IGC-1C Modulates Tau LLPS, Inhibits and Dissolves Condensates - Stock Titan
Will IGC Pharma Inc. (IGS1) stock rise with strong economy2025 Price Momentum & Fast Exit Strategy with Risk Control - newser.com
IGC Pharma, Inc. (NYSEAMERICAN:IGC) Sees Significant Decline in Short Interest - Defense World
Is IGC Pharma Inc. (IGS1) stock inflation resilient2025 Fundamental Recap & Consistent Profit Alerts - newser.com
Real time scanner hits for IGC Pharma Inc. explained2025 Market Overview & Weekly High Potential Stock Alerts - newser.com
Is IGC Pharma Inc. stock a buy in volatile marketsLong Setup & Weekly Top Gainers Alerts - newser.com
How IGC Pharma Inc. stock benefits from global expansionEarnings Summary Report & Weekly Market Pulse Updates - newser.com
Is IGC Pharma Inc. stock a contrarian buy2025 Investor Takeaways & Free Fast Entry Momentum Trade Alerts - newser.com
Can IGC Pharma Inc. hit a new high this monthMarket Rally & Weekly Market Pulse Updates - newser.com
How institutional ownership impacts IGC Pharma Inc. stockMarket Trend Review & Verified Technical Signals - newser.com
Institutional scanner results for IGC Pharma Inc.2025 Market Sentiment & Smart Investment Allocation Tips - newser.com
Can IGC Pharma Inc. stock attract ESG capital inflowsJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com
What analysts say about IGC Pharma Inc IGS1 stockMid Cap Growth Trends & Low Risk Portfolio Growth - earlytimes.in
Finanzdaten der IGC Pharma Inc-Aktie (IGC)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):